We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT05111626
Brief Title: Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer (FORTITUDE-102)
First Submitted : October 29, 2021
First Submitted that Met QC Criteria : October 29, 2021
First Posted : November 8, 2021
Last Update Submitted that Met QC Criteria : May 24, 2023
Last Update Posted : May 25, 2023